ID
22101
Description
A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT01153971
Link
https://clinicaltrials.gov/show/NCT01153971
Keywords
Versions (1)
- 5/19/17 5/19/17 -
Uploaded on
May 19, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non-Hodgkin's Lymphoma NCT01153971
Eligibility Non-Hodgkin's Lymphoma NCT01153971
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Chronic Lymphocytic Leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0023434
Description
Malignant Neoplasms | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
- UMLS CUI [2]
- C0007117
- UMLS CUI [3]
- C0553723
- UMLS CUI [4]
- C0851140
Description
CORTICOSTEROIDS FOR SYSTEMIC USE
Data type
boolean
Alias
- UMLS CUI [1]
- C3653708
Description
Cardiovascular Disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0007222
Description
Central Nervous System Involvement
Data type
boolean
Alias
- UMLS CUI [1]
- C4050309
Description
Hepatitis B | Hepatitis C | HIV Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0019163
- UMLS CUI [2]
- C0019196
- UMLS CUI [3]
- C0019693
Similar models
Eligibility Non-Hodgkin's Lymphoma NCT01153971
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0234227 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
C1314939 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0851140 (UMLS CUI [4])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])